Mad in America

JUNE 13, 2024

I surprised myself at how much I enjoyed the experience of interviewing these interesting patients. I had to learn to recognise my survival persona, one who was easily controlled and coerced. At last, I started to process memories and emotions that had remained suppressed for decades.

Training 145

Training Pharmaceutical Consulting Influencing 145

Mad in America

JANUARY 6, 2024

I decided to turn my professional eye on BetterHelp, the largest and most prominent of these services, seeking my own psychotherapy with the company, applying and getting hired as a therapist, and interviewing BetterHelp clinicians. For me, it’s quality control,” Wampold said. “Is The background check was completed quickly.

Insurance 144

Insurance Consulting Advertising Controlling 144

Mad in America

OCTOBER 25, 2023

In this interview, we talk about her experiences of withdrawal from a cocktail of psychiatric drugs and her debut memoir, May Cause Side Effects , published in 2022 which is one of the first books on antidepressant withdrawal to make it to the mass market. Listen to the audio of the interview here. James Moore: Brooke, welcome.

Interviewing 145

Interviewing Pharmaceutical Food Reporting 145

Mad in America

DECEMBER 13, 2023

You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here.

Pharmaceutical 143

Pharmaceutical Problem-Solving Finance Reporting 143

Mad in America

OCTOBER 24, 2024

published an article online with interviews of professionals about their experiences of working with the implementation of the Norwegian action plans and guidelines for suicide prevention. [9] 18] Goldney had received “gold” “from a number of pharmaceutical companies.” It was exceedingly difficult for Hjelmeland et al.

Pharmaceutical 145

Pharmaceutical Reporting Controlling Correspondence 145

Tanveer Naseer

MARCH 10, 2015

For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” As he put it in an interview in 2014, “I always thought it was kind of stupid if you have this big company, and you can only do, like, five things.” This is quite understandable.

Retail 107

Retail Automotive Computer Pharmaceutical 107

Mad in America

SEPTEMBER 21, 2024

That was just a lot less salient abroad,” she pointed out in an interview. For years, the 40-year-old from India’s Panipat lived in fear—she was convinced that a spirit had taken control of her. While his sons eventually recovered, he and his wife remained under the spirit’s control. The spirit talks to us, makes fun of us.

Problem-Solving 125

Problem-Solving Reporting Food Influencing 125

Inside Workplace Wellness

AUGUST 1, 2018

Characteristics typically include: Qualities that make for costly medication delivery, such as requirements for professional administration or special handling e.g., temperature control. Does your PBM require providers to use NDC coding for Specialty Pharmaceuticals to improve monitoring and tracking of utilization? ASHA uses $1,000.

Pharmaceutical 52

Pharmaceutical Mailing Insurance Maintenance 52

Success

FEBRUARY 15, 2022

His Get Attitude podcast won a Communicator Award for Diversity & Inclusion for his 8:46 Interviews Stories of Black America. As a keynote speaker, she has shared the stage with many influencers, including a recent interview with Venus Williams. Candy Valentino. Entrepreneur, CEO, founder.

Real Estate 124

Real Estate Coaching Mentoring Sales 124

Mad in America

JANUARY 9, 2024

So well that no Randomized Controlled Trials (RCTs) were needed to show they worked. They might be randomizing, and controlling with a placebo, but they were doing Assays—Randomized Controlled Assays (RCAs). Standardizing clinical interviews risks disaster. Who said no RCTs were needed? What’s an Assay? And they don’t.

Healthcare 139

Healthcare Pharmaceutical Problem-Solving Controlling 139

Mad in America

NOVEMBER 6, 2024

In this interview, Cartwright charts her journey of painful and lonely disillusionment with the “mental illness” framework. In this brutally honest book and interview, Cartwright reflects on the importance of holding all our understandings around mental health and suffering, lightly. Listen to the audio of the interview here.

Interviewing 117

Interviewing Problem-Solving Reporting Pharmaceutical 117

Mad in America

MARCH 26, 2025

Before we begin, I’d like to take a few moments and explain the context of this interview. Third, his journal told of the corrupting influence of pharmaceutical money on the creation of psychiatric diagnoses and drug trials. Listen to the audio of the interview here. W elcome to Mad In America Radio.

Interviewing 93

Interviewing Pharmaceutical Reporting Controlling 93

Mad in America

JANUARY 4, 2025

Given the dearth of controlled data (in real-world patients groups), results should have substantial public health and scientific significance, since they are obtained in representative participant groups/settings, using clinical management tools that can easily be applied in daily practice, the STAR*D investigators wrote.

Pharmaceutical 145

Pharmaceutical Reporting Promotion Interviewing 145

Mad in America

MARCH 22, 2025

The journal continued to be in good hands, and thus one of the few journals that was receptive to research findings that belied the narrative of therapeutic progress that the psychiatric guild and pharmaceutical companies have been promoting for decades. He noted too the reluctance of the field to consider this possibility.

Pharmaceutical 135

Pharmaceutical Reporting Leadership Controlling 135

Mad in America

MARCH 8, 2025

” This interview was conducted by email. He also sent me to colleagues who had special knowledge of specific areas such as having a control group who did not have the rehab program, as well as scales and schedules to use in interviews, and which statistics to use. We began interviewing in 1980.

Interviewing 142

Interviewing Reporting Pharmaceutical Consulting 142

Mad in America

APRIL 30, 2025

Listen to the audio of the interview here. Then, probably the same year it’s picked up by Eli Lilly, the makers of Prozac, and other pharmaceutical companies who come along with their SSRIs, and they breathe new life into it and recruit this idea, which has already been disproven, to market antidepressants.

Pharmaceutical 144

Pharmaceutical Networking Reporting Interviewing 144

Mad in America

APRIL 23, 2025

Editor’s note: This is an interview conducted by Tiago Pires Marques, editor of Mad in Portugal. The interview was initially conducted on February 27, 2017, and then updated recently for publication on Mad in Portugal. The interview is an abbreviated version of the interview published in Mad in Portugal (1).

Interviewing 95

Interviewing Networking Pharmaceutical Government 95

Mad in America

MAY 3, 2025

Corruption by pharmaceutical companies. One would hope that this distinction would now be clear to Aftab after interviewing Cooper Davis, Executive Director of Inner Compass Initiative, who told him in 2025: We are not anti-psychiatry, anti-drug, or anti-diagnosis.

Reporting 120

Reporting Pharmaceutical Correspondence Promotion 120

Mad in America

APRIL 25, 2025

A seasoned psychiatrist interviewed me, a woman with short, dark, puffy hair and a stern demeanor. She interviewed my mother, striving to understand my history. With samples from a pharmaceutical company eager to gain a new client, Dr. Y also prescribed a benzodiazepine to improve sleep and ease symptoms.

Problem-Solving 84

Problem-Solving Pharmaceutical Food Planning 84

Mad in America

MARCH 5, 2025

Listen to the audio of the interview here. I encourage everyone to read itit gives a powerful overview of how quickly things spiraled out of control. They interviewed us for four hours and brought the two main doctors up on charges. My name is Brooke Siem, and Im the author of May Cause Side Effects. He never practiced again.

Insurance 139

Insurance Mentoring Pharmaceutical Legal 139

Mad in America

FEBRUARY 12, 2025

Listen to the audio of the interview here. Thats not a leap people often makefrom philosophical psychology to critiques of the pharmaceutical industry and medicalization. She was deeply involved in critical psychiatry and critiques of the pharmaceutical industry. The transcript below has been edited for length and clarity.

Influencing 142

Influencing Problem-Solving Training Pharmaceutical 142

Mad in America

MARCH 19, 2025

In this interview, he explores the philosophical foundations of psychology, the psychological costs of neoliberalism, and why developing a critical psychology of education and mental health is more urgent than ever. Listen to the audio of the interview here. The supposed freedom of choice conceals deeper forms of control.

Government 140

Government Controlling Influencing Interviewing 140